However, it should be noted that experimentsutilising anti-IL-1 treatments have not yet been tested in humans and when given alone, anti-IL-1 treatments do not reduce the burden of existing bone metastasis and can increase growth of soft tissue tumours. Here, IL1B is linked to soft tissue neoplasm.